ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NIOX Niox Group Plc

61.00
0.60 (0.99%)
Last Updated: 10:02:47
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Niox Group Plc LSE:NIOX London Ordinary Share GB00BJVD3B28 ORD 0.08P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.60 0.99% 61.00 60.20 62.00 62.00 61.00 61.00 9,644 10:02:47
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 36.8M 9.5M 0.0224 27.23 256.17M
Niox Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker NIOX. The last closing price for Niox was 60.40p. Over the last year, Niox shares have traded in a share price range of 57.20p to 75.40p.

Niox currently has 424,127,241 shares in issue. The market capitalisation of Niox is £256.17 million. Niox has a price to earnings ratio (PE ratio) of 27.23.

Niox Share Discussion Threads

Showing 51 to 75 of 250 messages
Chat Pages: 10  9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
04/5/2023
16:19
Looks about ready for a run.
p1nkfish
04/5/2023
15:21
Seller may be clearing, close to breaking 50p.
saadia110
04/5/2023
11:50
50p to buy.... :)
thedudie
04/5/2023
10:57
OK found it
"Once FeNO testing and NIOX® are established as normal practice in Primary Care the Company plans to explore a home use product, so that asthma patients can perform a FeNO test at home and help improve their asthma outcomes."
apad

apad
04/5/2023
10:55
Missed "home-testing".
Reference?
apad

apad
04/5/2023
10:50
Good point dudie. News on home tasting kits will be the game changer. This is what will make it a razor blade stock.with those and volume of trades going through either people are taking a gamble now or news is leaking. Can’t see why there would be such a large seller at this stage of proceedings but obviously the shares have to be coming from somewhere.
earwacks
03/5/2023
15:46
There is normally a trading statement at the AGM (18th May this year). If trading has continued to improve I would think the high 50s would be in reach at least. More so if there is other news about home testing or anything else.
thedudie
03/5/2023
15:22
There must be a big seller unwinding their position so the share price struggles to move forward. Once the seller has cleared it will break 50p.
saadia110
03/5/2023
14:27
And now for something completely different a buy at 2.30 of 700000 shares and after several days relentless buying the share price moves up 2p. Whooppee.
earwacks
27/4/2023
14:27
Takes some buying to move this stock up. doing my bit still!
earwacks
24/4/2023
19:21
Trading update due middle of May hopefully more good news
bc4
24/4/2023
17:47
All the hall marks of a bid coming. Seems to be takeover season. Wonder who wants it apart from Astra. Absolute cash cow. 977,000 shares traded?That accounts for two trades, what about all the others
earwacks
28/3/2023
15:27
Hope it's not 4 yrs or so to get back to 70p.
No covid in the way this time and company in a better state overall.
How long before Dir's get their goodies and we get 55p-70p?

p1nkfish
28/3/2023
15:22
30 consecutive days, I won't complain when it gets there.

"33 percent of the Options will vest in the event that a Vesting Level of 55p is attained, 66 percent of the Options will vest in the event that a Vesting Level of 62.5p is attained, with 100 per cent. vesting in the event that a Vesting Level of 70p is attained."

Oct 2018 was last time at 70p approx.
Dec 2018 for 55p, approx.

p1nkfish
28/3/2023
15:17
Greed greed greed. As if they weren't well enough remunerated already. And RNS released after 4pm due to the shame of it all.
chrysalis99
21/3/2023
08:23
Singer Capital Markets issued a broker note this morning increasing its shareprice target to 56p.
masurenguy
21/3/2023
07:46
A great set of numbers given that there was a continuing Covid impact.
So after a 15% revenue increase in 2022 it looks like 2023 has started brightly with revenues up 19% for the first 2 months....

Good progress!

thedudie
21/3/2023
07:11
PRELIMINARY RESULTS FOR THE YEARED 31 DECEMBER 2022

21 March 2023: NIOX Group today announces unaudited results for the year ended 31 December 2022.

Financial highlights

-- Underlying revenue growth of 15% to £31.3 million (2021: £27.9 million) excluding a one-off revenue item of £0.6 million in China

-- Profit before tax £2.4 million, excluding the benefit of the Beyond Air consideration of £8.1 million (2021: loss of £2.1 million)

-- Group adjusted EBITDA(2) at £7.3 million, ahead of upgraded consensus estimates (2021: £0.6 million in a transitional year)

-- Net cash £19.4 million (31 December 2021: £12.6 million)

2022 was a good year for the Group. The results demonstrate the clear ability of our business model to generate profitable growth, and double digit sales growth at historical trend levels was achieved despite ongoing adverse effects of Covid-19 in several of our major markets. The business has made a positive start to 2023 and the Board expects another year of solid progress, notwithstanding the somewhat mixed macroeconomic outlook.

Ian Johnson, NIOX's Executive Chairman, said: "2022 was a significant year for the Group with the business substantially right-sized and the implementation of a distributor-led sales strategy well underway. These initiatives gave rise to a much-reduced cost base and generated scalable revenue growth. The Group remains debt free and has significant cash resources to continue implementing its business strategy of accessing and promoting the benefits of its products to healthcare professionals in primary and secondary care, who diagnose and treat the large population of patients suffering from asthma. Significant progress was made in 2022 to sell NIOX(R) FeNO devices into primary care, and I am pleased to report that this is continuing into 2023.

The business has proved very resilient during both the Pandemic and the more recent global macroeconomic conditions. The high level of recurring revenues provides good visibility of earnings and together with high gross margins are delivering profitable growth. The Group has made a positive start to 2023 with revenues up 19% in the first two months of the year on the equivalent period in 2022. The Board believes that the strong business model will drive further top line growth and continue to deliver improved shareholder value going forward."

masurenguy
18/3/2023
12:46
I guess a buyback is coming??
edwardt
15/3/2023
16:33
Very encouraging to see a small rise into the close on a big down day in the market.
masurenguy
09/3/2023
12:31
The market is quite illiquid . Cant get a quote on some quite decent stock I hold. Not that I want to sell. However no problem to sell quite sizeable holding in one go on Niox. Fortunately hit the right button to decline! If it was an overhang they have quite a few to sell. Market makers probably pretty pleased to bag 7 million at 45p if thats what happened. If that had been dumped on the open market would be back to 40p or less I would have thought
earwacks
09/3/2023
12:10
Well 50p did not hold hopefully another go soon
bc4
08/3/2023
11:42
Well those 7.6 million was bought by somebody!.Also it might have cleared a overhang
bc4
08/3/2023
10:34
Hold? Yesterday over 7.6 million sold and share price goes up. Today a 100 bot trade takes the share price down to 48p! Crazy. Trend is undeniable though:)
earwacks
08/3/2023
09:43
Nice spike to 50p lets hope it holds
bc4
Chat Pages: 10  9  8  7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock